Geographic variation in chronic obstructive pulmonary disease exacerbation rates

Journal of General Internal Medicine

Volumn 22, Issue 11, 2007, Pages 1560-1565

  Joo, Min J ^a,b,c   Lee, Todd A ^a,b   Weiss, Kevin B ^a,b  

^a HINES VA HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

COPD; Exacerbation; Geographic variation; Outcomes

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE; HEALTH SERVICE; HUMAN; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS;

EID: 35248831615     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0354-6     Document Type: Article

References (33)

1. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1278-85.
2. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117:5S-9S.
3. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847-52.
4. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164:358-64.
5. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101:1305-12.
6. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59:387-95.
7. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698-702.
8. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-22.
9. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997;52:67-71.
10. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129:1509-15.
11. Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340:32-9.
12. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144:894-903.
13. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s-53s.
14. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608-13.
15. The United States Department of Commerce. Climatography of the United States Report No. 85 (Divisional Normals and Standard Deviations of Temperature, Precipitation, and Heating and Cooling Degree Days, 1971-2000); 2003.
16. Byers AL, Allore H, Gill TM, Peduzzi PN. Application of negative binomial modeling for discrete outcomes: a case study in aging research. J Clin Epidemiol. 2003;56:559-64.
17. Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118:392-404.
18. Slymen DJ, Ayala GX, Arredondo EM, Elder JP. A demonstration of modeling count data with an application to physical activity. Epidemiol Perspect Innov. 2006;3:3.
19. Veterans Health Administration. Available at: http://www1.va.gov/ directory/guide/division_flsh.asp?dnum=1. Accessed April 30, 2007.
20. Menon V, Rumsfeld JS, Roe MT, et al. Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes. Am J Med. 2006;119:584-90.
21. Krumholz HM, Chen J, Rathore SS, Wang Y, Radford MJ. Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage. Am Heart J. 2003;146:242-9.
22. Subramanian U, Weinberger M, Eckert GJ, L'Italien GJ, Lapuerta P, Tierney W. Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction. J Gen Intern Med. 2002;17:604-11.
23. Lougheed MD, Garvey N, Chapman KR, et al. The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest. 2006;129:909-17.
24. Weinstein JN, Bronner KK, Morgan TS, Wennberg JE. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine. Health Aff (Millwood). 2004;Suppl Web Exclusive:VAR81-9.
25. Doherty MJ, Greenstone MA. Survey of non-invasive ventilation (NIPPV) in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) in the UK. Thorax. 1998;53:863-6.
26. Kinnunen T, Saynajakangs O, Tuuponen T, Keistinen T. Regional and seasonal variation in the length of hospital stay for chronic obstructive pulmonary disease in Finland. Int J Circumpolar Health. 2002;61:131-5.
27. Maheshwari V, Paioli D, Rothaar R, Hill NS. Utilization of noninvasive ventilation in acute care hospitals: a regional survey. Chest. 2006;129:1226-33.
28. Ringbaek TJ, Lange P, Viskum K. Geographic variation in long-term oxygen therapy in Denmark: factors related to adherence to guidelines for long-term oxygen therapy. Chest. 2001;119:1711-6.
29. Helmer DA, Tseng CL, Brimacombe M, Rajan M, Stiptzarov N, Pogach L. Applying diabetes-related prevention quality indicators to a national cohort of veterans with diabetes. Diabetes Care. 2003;26:3017-23.
30. Murdoch M, Hodges J, Cowper D, Sayer N. Regional variation and other correlates of Department of Veterans Affairs Disability Awards for patients with posttraumatic stress disorder. Med Care. 2005;43:112-21.
31. Tseng CL, Greenberg JD, Helmer D, et al. Dual-system utilization affects regional variation in prevention quality indicators: the case of amputations among veterans with diabetes. Am J Manag Care. 2004;10:886-92.
32. Wilt TJ, Cowper DC, Gammack JK, Going DR, Nugent S, Borowsky SJ. An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care. 1999;37:1046-56.
33. Jones PW, Willits LR, Burge PS, Calverley PM. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J. 2003;21:68-73.